This site is intended for Healthcare Professionals only.

EU lists rare nerve disorder as possible side-effect of AstraZeneca Covid-19 vaccine


Share post:

Europe’s medicines regulator has added a rare nerve-damaging disorder, Guillain-Barré syndrome, as a possible sideeffect of AstraZeneca‘s Covid19 vaccine, regular safety updates from the watchdog showed on Wednesday.

The European Medicines Agency also tagged some other less severe sideeffects to vaccines from Johnson & Johnson, Moderna as well as AstraZEneca’s shot.


Please enter your comment!
Please enter your name here

Current Issue June 2024

Related articles

FIP supports PDA’s Safer Pharmacies Charter

PDA urges all UK pharmacists to take part in the 2024 Safer Pharmacies Survey The International Pharmaceutical Federation...

Topiramate should not be prescribed for epilepsy during pregnancy unless…

MHRA tightens safety measures for topiramate by introducing a new pregnancy prevention programme  Healthcare professionals in the UK are...

WHO issues alert on fake copies of Novo Nordisk’s diabetes drug Ozempic

Falsified batches of Ozempic (semaglutide) were detected in Brazil, the UK, Northern Ireland and the United States The...

Synnovis cyber attack: NHS patient data leaked, services impacted

The NHS has set up helpline number to answer queries and concerns about patient data as Synnovis cyber...